Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance - PubMed (original) (raw)
Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance
J A Posada et al. Cancer Commun. 1989.
Abstract
Among the many phenotypic characteristics of multidrug resistance (MDR), the presence of P-glycoprotein is nearly always observed, and it appears that the plasma membrane of the multidrug resistant cell is integrally involved in controlling drug resistance. Another membrane-associated protein kinase, protein kinase C (PKC), has been shown to regulate the flow of information to the cell interior and to control the efflux of a number of different compounds. We therefore initiated a study of PKC and MDR. We found that multidrug resistant sublines from both mouse sarcoma 180 and human KB lines exhibited 80-90% increases in basal PKC activity. The mechanism of the increase appears to be quite different in the two cell lines. The human KB cells overexpress the alpha isozyme of PKC, commensurate with the increase in alpha-PKC protein, whereas the mouse cells do not overexpress alpha-mRNA but increase alpha-PKC protein. Furthermore, it appears that PKC activity plays a functional role in drug resistance, since inhibition of endogenous PKC activity by staurosporine resulted in decreased resistance to Adriamycin. We also found that phosphorylation of MDR cell membrane vesicles by purified PKC, followed by immunoprecipitation of P-glycoprotein with monoclonal antibody C219, resulted in a level of phosphorylation of P-glycoprotein that was greater than the endogenous phosphorylation level. The data presented indicate that MDR cells of diverse species exhibited enhanced PKC activity but that the mechanisms were different. The increased kinase activity may have biological relevance to MDR since PKC appears to be coupled to P-glycoprotein function.
Similar articles
- Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha.
Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Wetsel WC, Obeid LM, Fine RL, Hannun YA. Blobe GC, et al. J Biol Chem. 1993 Jan 5;268(1):658-64. J Biol Chem. 1993. PMID: 8093247 - The protein kinase C inhibitor CGP 41251, a staurosporine derivative with antitumor activity, reverses multidrug resistance.
Utz I, Hofer S, Regenass U, Hilbe W, Thaler J, Grunicke H, Hofmann J. Utz I, et al. Int J Cancer. 1994 Apr 1;57(1):104-10. doi: 10.1002/ijc.2910570119. Int J Cancer. 1994. PMID: 7908658 - Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells.
Chambers TC, McAvoy EM, Jacobs JW, Eilon G. Chambers TC, et al. J Biol Chem. 1990 May 5;265(13):7679-86. J Biol Chem. 1990. PMID: 1970571 - P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D, Skovsgaard T. Nielsen D, et al. Biochim Biophys Acta. 1992 Jul 7;1139(3):169-83. doi: 10.1016/0925-4439(92)90131-6. Biochim Biophys Acta. 1992. PMID: 1352705 Review. - Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistance.
Hait WN, Aftab DT. Hait WN, et al. Biochem Pharmacol. 1992 Jan 9;43(1):103-7. doi: 10.1016/0006-2952(92)90667-8. Biochem Pharmacol. 1992. PMID: 1346493 Review.
Cited by
- Towards selective pharmacological modulation of protein kinase C--opportunities for the development of novel antineoplastic agents.
Gescher A. Gescher A. Br J Cancer. 1992 Jul;66(1):10-9. doi: 10.1038/bjc.1992.209. Br J Cancer. 1992. PMID: 1637658 Free PMC article. Review. No abstract available. - Characteristics of erythroleukemia cells selected for vincristine resistance that have accelerated inducer-mediated differentiation.
Richon VM, Weich N, Leng L, Kiyokawa H, Ngo L, Rifkind RA, Marks PA. Richon VM, et al. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1666-70. doi: 10.1073/pnas.88.5.1666. Proc Natl Acad Sci U S A. 1991. PMID: 1672043 Free PMC article. - Effects of phosphorylation of P-glycoprotein on multidrug resistance.
Germann UA, Chambers TC, Ambudkar SV, Pastan I, Gottesman MM. Germann UA, et al. J Bioenerg Biomembr. 1995 Feb;27(1):53-61. doi: 10.1007/BF02110331. J Bioenerg Biomembr. 1995. PMID: 7629052 Review. - Protein kinases and multidrug resistance.
Rumsby MG, Drew L, Warr JR. Rumsby MG, et al. Cytotechnology. 1998 Sep;27(1-3):203-24. doi: 10.1023/A:1008073006495. Cytotechnology. 1998. PMID: 19002793 Free PMC article. - Comparison of ability of protein kinase C inhibitors to arrest cell growth and to alter cellular protein kinase C localisation.
Courage C, Budworth J, Gescher A. Courage C, et al. Br J Cancer. 1995 Apr;71(4):697-704. doi: 10.1038/bjc.1995.137. Br J Cancer. 1995. PMID: 7710931 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources